The combination of silencing BAG3 and inhibition of the JNK pathway enhances hyperthermia sensitivity in human oral squamous cell carcinoma cells

Cancer Letters

Volumn 335, Issue 1, 2013, Pages 52-57

  Yunoki, Tatsuya ^a   Kariya, Ayako ^a   Kondo, Takashi ^a   Hayashi, Atsushi ^a   Tabuchi, Yoshiaki ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Apoptosis; BAG3; Hyperthermia; JNK pathway

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BAG3 PROTEIN; CASPASE 3; CHAPERONE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BAG3 GENE; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTHRACENES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; HEAT-SHOCK RESPONSE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MOUTH NEOPLASMS; RNA INTERFERENCE; TRANSCRIPTIONAL ACTIVATION;

EID: 84878463676     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.01.049     Document Type: Article

References (46)

1. Scully C., Bagan J.V. Recent advantages in oral oncology, squamous cell carcinoma imaging, treatment, prognostication and treatment outcomes. Oral Oncol. 2008, 45(2009):e25-e30.
2. Cruz J.J., Ocaña A., Navarro M., Barco E.D., Fonseca E. New options in the treatment of locally advanced head and neck cancer: role for induction chemotherapy. Cancer Treat. Rev. 2008, 34:268-274.
3. Wust P., Hildebrandt B., Sreenivasa G., Rau B., Gellermann J., Riess H., Felix R., Schlag P.M. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002, 3:487-497.
4. Huilgol N.G., Gupta S., Dixit R. Chemoradiation with hyperthermia in the treatment of head and neck cancer. Int. J. Hyperthermia 2010, 26:21-25.
5. Wust P., Stahl H., Dieckmann K., Scheller S., Löffel J., Riess H., Bier J., Jahnke V., Felix R. Local hyperthermia of N2/N3 cervical lymph node metastases: correlation of technical/thermal parameters and response. Int. J. Radiat. Oncol. Biol. Phys. 1996, 34:635-646.
6. Tohnai I., Hayashi Y., Mitsudo K., Shigetomi T., Ueda M., Ishigaki T. Prognostic evaluation of preoperative thermochemoradiotherapy for N (3) cervical lymph node metastases of oral cancer. Oncology 2002, 62:234-240.
7. van der Zee J., González González D., van Rhoon G.C., van Dijk J.D., van Putten W.L., Hart A.A. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000, 355:1119-1125.
8. Harima Y., Nagata K., Harima K., Ostapenko V.V., Tanaka Y., Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int. J. Hyperthermia 2001, 17:97-105.
9. Xia H., Karasawa K., Hanyu N., Chang T.C., Okamoto M., Kiguchi Y., Kawakami M., Itazawa T. Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma. Int. J. Hyperthermia 2006, 22:613-621.
10. Aktas M., de Jong D., Nuyttens J.J., van der Zee J., Wielheesen D.H., Batman E., Burger C.W., Ansink A.C. Concomitant radiotherapy and hyperthermia for primary carcinoma of the vagina: a cohort study. Eur. J. Obset. Gynecol. Reprod. Biol. 2007, 133:100-104.
11. Van Der Zee J., De Bruijne M., Mens J.W., Ameziane A., Broekmeyer-Reurink M.P., Drizdal T., Linthorst M., Van Rhoon G.C. Rradiation combined with hyperthermia in breast cancer recurrences: overview of experience in Erasmus MC. Int. J. Hyperthermia 2010, 26:638-648.
12. Parsell D.A., Lindquist S. The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Ann. Rev. Genet. 1993, 27:437-496.
13. Ohtsuka K., Hata M. Molecular chaperone function of mammalian Hsp70 and Hsp40 - a review. Int. J. Hyperthermia 2000, 16:231-245.
14. Takayama S., Xie Z., Reed J.C. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J. Biol. Chem. 1999, 274:781-786.
15. Rosati A., Ammirante M., Gentilella A., Basile A., Festa M., Pascale M., Marzullo L., Belisario M.A., Tosco A., Franceschelli S., Moltedo O., Pagliuca G., Lerose R., Turco M.C. Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein, Int. J. Biochem. Cell Biol. 2007, 39:1337-1342.
16. Franceschelli S., Rosati A., Lerose R., De Nicola S., Turco M.C., Pascale M. Bag3 gene expression is regulated by heat shock factor 1, J. Cell. Physiol. 2008, 215:575-577.
17. Bonelli P., Petrella A., Rosati A., Romano M.F., Lerose R., Pagliuca M.G., Amelio T., Festa M., Martire G., Venuta S., Turco M.C., Leone A. BAG3 protein regulates stress-induced apoptosis in normal and neoplastic leukocytes. Leukemia 2006, 18:358-360.
18. Pagliuca M.G., Lerose R., Cigliano S., Leone A. Regulation by heavy metals and temperature of the human BAG-3 gene, a modulator of Hsp70 activity. FEBS Lett. 2003, 541:11-15.
19. Liao Q., Ozawa F., Friess H., Zimmermann A., Takayama S., Reed J.C., Kleeff J., Büchler M.W. The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines. FEBS Lett. 2001, 503:151-157.
20. Tabuchi Y., Ando H., Takasaki I., Feril L.B., Zhao Q.L., Ogawa R., Kudo N., Tachibana K., Kondo T. Identification of genes responsive to low intensity pulsed ultrasound in a human leukemia cell line Molt-4. Cancer Lett. 2007, 246:49-56.
21. Chen L., Wu W., Dentchev T., Zeng Y., Wang J., Tsui I., Tobias J.W., Bennett J., Baldwin D., Dunaief J.L. Light damage induced changes in mouse retinal gene expression. Exp. Eye. Res. 2004, 79:239-247.
22. Rosati A., Khalili K., Deshmane S.L., Radhakrishnan S., Pascale M., Turco M.C., Marzullo L. BAG3 protein regulates caspase-3 activation in HIV-1-infected human primary microglial cells. J. Cell. Physiol. 2009, 218:264-267.
23. Chiappetta G., Ammirante M., Basile A., Rosati A., Festa M., Monaco M., Vuttariello E., Pasquinelli R., Arra C., Zerilli M., Todaro M., Stassi G., Pezzullo L., Gentilella A., Tosco A., Pascale M., Marzullo L., Belisario M.A., Turco M.C., Leone A. The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J. Clin. Endocrinol. Metab. 2007, 92:1159-1163.
24. Staibano S., Mascolo M., Di Benedetto M., Vecchione M.L., Ilardi G., Di Lorenzo G., Autorino R., Salerno V., Morena A., Rocco A., Turco M.C., Morelli E. BAG3 protein delocalisation in prostate carcinoma. Tumor Biol. 2010, 31:461-469.
25. Wang H.Q., Liu B.Q., Gao Y.Y., Meng X., Guan Y., Zhang H.Y., Du Z.X. Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression. Br. J. Pharmacol. 2009, 158:1405-1412.
26. Festa M., Del Valle L., Khalili K., Franco R., Scognamiglio G., Graziano V., De Laurenzi V., Turco M.C., Rosati A. BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am. J. Pathol. 2011, 178:2504-2512.
27. Suzuki M., Iwasaki M., Sugio A., Hishiya A., Tanaka R., Endo T., Takayama S., Saito T. BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells. Cancer Lett. 2011, 303:65-71.
28. Liu P., Xu B., Li J., Lu H. BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis. FEBS Lett. 2009, 583:401-406.
29. Du Z.X., Meng X., Zhang H.Y., Guan Y., Wang H.Q. Caspase-dependent cleavage of BAG3 in proteasome inhibitors-induced apoptosis in thyroid cancer cells. Biochem. Biophys. Res. Commun. 2008, 369:894-898.
30. Wang H.Q., Liu H.M., Zhang H.Y., Guan Y., Du Z.X. Transcriptional upregulation of BAG3 upon proteasome inhibition. Biochem. Biophys. Res. Commun. 2007, 365:381-385.
31. Zhu H., Liu P., Li J. BAG3: a new therapeutic target of human cancers?. Histol. Histopathol. 2012, 3:257-261.
32. Alcala M.A., Park K., Yoo J., Lee D.H., Park B.H., Lee B.C., Bartlett D.L., Lee Y.J. Effect of hyperthermia in combination with TRAIL on the JNK-Bim signal transduction pathway and growth of xenograft tumors. J. Cell. Biochem. 2010, 110:1073-1081.
33. Hayashi S., Koshiba K., Hatashita M., Sato T., Jujo Y., Suzuki R., Tanaka Y., Shioura H. Thermosensitization and induction of apoptosis or cell-cycle arrest via the MAPK cascade by parthenolide, an NF-κB inhibitor, in human prostate cancer androgen-independent cell lines. Int. J. Mol. Med. 2011, 28:1042-2033.
34. Gaitanaki C., Mastri M. Aggeli IK, Beis I, Differential roles of p38-MAPK and JNKs in mediating early protection or apoptosis in the hyperthermic perfused amphibian heart. J. Exp. Biol. 2008, 211:2524-2532.
35. Gabai V.L., Yaglom J.A., Volloch V., Meriin A.B., Force T., Koutroumanis M., Massie B., Mosser D.D., Sherman M.Y. Hsp72-mediated suppression of c-Jun N-terminal kinase is implicated in development of tolerance to caspase-independent cell death. Mol. Cell. Biol. 2000, 20:6826-6836.
36. Chung H.S., Park S.R., Choi E.K., Park H.J., Griffin R.J., Song C.W., Park H. Role of sphingomyelin-MAPKs pathway in heat-induced apoptosis. Exp. Mol. Med. 2003, 35:181-188.
37. Sloss C.M., Wang F., Liu R., Xia L., Houston M., Ljungman D., Palladino M.A., Cusack J.C. Proteasome inhibition activates epidermal growth factor receptor (EGFR) and EGFR-independent mitogenic kinase signaling pathways in pancreatic cancer cells. Clin. Cancer Res. 2008, 14:5116-5123.
38. 2-induced apoptosis of PC-12 cells. Phytomedicine 2011, 18:843-847.
39. Furusawa Y., Izumi T., Fujiwara Y., Zhao Q.L., Tabuchi Y. Kondo T, Inhibition of checkpoint kinase 1 abrogates G2/M checkpoint activation and promotes apoptosis under heat stress. Apoptosis 2012, 17:102-112.
40. Nicholson D.W. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat. Biotechnol. 1996, 14:297-301.
41. Lu Y.Y., Chen T.S., Wang X.P., Qu J.L., Chen M. The JNK inhibitor SP600125 enhances dihydroartemisinin-induced apoptosis by accelerating Bax translocation into mitochondria in human lung adenocarcinoma cells. FEBS Lett. 2010, 584:4019-4026.
42. Tabuchi Y., Wada S., Furusawa Y., Kondo T. Gene networks related to the cell death elicited by hyperthermia in human oral squamous cell carcinoma HSC-3 cells. Int. J. Mol. Med. 2012, 29:380-386.
43. Ammirante M., Rosati A., Arra C., Basile A., Falco A., Festa M., Pascale M., d'Avenia M., Marzullo L., Belisario M.A., De Marco M., Barbieri A., Giudice A., Chiappetta G., Vuttariello E., Monaco M., Bonelli P., Salvatore G., Di Benedetto M., Deshmane S.L., Khalili K., Turco M.C., Leone A. IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc. Natl. Acad. Sci. USA 2010, 107:7497-7502.
44. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 2002, 4:E131-E136.
45. Meriin A.B., Gabai V.L., Yaglom J., Shifrin V.I., Sherman M.Y. Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis. J. Biol. Chem. 1998, 273:6373-6379.
46. Kim Y.H., Park E.J., Han S.T., Park J.W., Kwon T.K. Arsenic trioxide induces Hsp70 expression via reactive oxygen species and JNK pathway in MDA231 cells. Life Sci. 2005, 77:2783-2793.